uric acid has been researched along with Bronchopulmonary Dysplasia in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gestational age, endotracheal infection, and septicaemia had good predictive power." | 1.32 | Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. ( Collard, KJ; Godeck, S; Holley, JE; Quinn, MW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collard, KJ | 1 |
| Godeck, S | 1 |
| Holley, JE | 1 |
| Quinn, MW | 1 |
| Luukkainen, P | 1 |
| Aejmelaeus, R | 1 |
| Alho, H | 1 |
| Metsä-Ketelä, T | 1 |
| Ikonen, SR | 1 |
| Salo, MK | 1 |
| Vyas, JR | 1 |
| Currie, A | 1 |
| Dunster, C | 1 |
| Kelly, FJ | 1 |
| Kotecha, S | 1 |
3 other studies available for uric acid and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies.
Topics: Aging; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cohort | 2004 |
Plasma chain-breaking antioxidants in preterm infants with good and poor short-term outcome.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Bilirubin; Bronchopulmonary Dysplasia; Case-Control | 1999 |
Ascorbate acid concentration in airways lining fluid from infants who develop chronic lung disease of prematurity.
Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dy | 2001 |